Search
Now showing items 1-7 of 7
Multiple myeloma: managing a complex blood cancer
(Mark Allen Healthcare, 2016-09-10)
This article gives a comprehensive overview of multiple myeloma (MM), a complex blood cancer involving overproduction of plasma cells. Although MM remains incurable, patients are living longer as a result of multiple ...
Home administration of bortezomib: Making a difference to myeloma patients' lives
(Elsevier, 2009-10-08)
Multiple myeloma is a clonal malignancy of plasma cells, characterized by anaemia, renal dysfunction, lytic bone lesions and the presence of excess monoclonal immunoglobulin. It is the second most common hematological ...
Myelodysplastic syndromes: update and nursing considerations
(RCN Publishing, 2015-04-01)
This article provides nurses with an update on diagnosis, management and care of patients with myelodysplastic syndromes (MDS), a complex group of disorders of the bone marrow. MDS has wide-ranging effects on patients’ ...
Treatment for acute leukaemia: elderly patients’ lived experiences
(Mark Allen Healthcare, 2010-01-14)
Aim: The aim of this study was to explore the lived experiences of elderly patients with acute leukaemia receiving chemotherapy. Method: Seven elderly patients were interviewed and van Manen’s approach to data analysis was ...
Promoting quality of life for patients with myeloma
(RCN Publishing, 2013-08-02)
This article aims to provide nurses with an update of best practice in caring for patients living with a diagnosis of myeloma. Targeted treatments for myeloma have resulted in extended survival for patients. However, ...
Acute leukaemia: making sense of a complex blood cancer
(Mark Allen Healthcare, 2013-08-16)
Acute leukaemia represents a diverse group of blood cancers that affect both children and adults. Treatment schedules for these haematology cancers are often prolonged, with many associated side effects and complications. ...
Myeloma: making sense of a complex blood cancer
(Mark Allen Healthcare, 2010)
Myeloma is a challenging blood cancer characterized by bone destruction, hypercalcaemia, renal insufficiency and anaemia. Although myeloma remains incurable, recent advancements in treatments have resulted in significant ...